CareDx, Inc. Hits New 52-Week High of $24.11, Up 58.58%

CareDx, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 24.11 on June 11, 2026. This achievement underscores the company's strong performance over the past year, with a remarkable increase of 58.58%, significantly outpacing the S&P 500's growth of 22.78% during the same period. The company has demonstrated impressive financial metrics, including a substantial operating profit growth of 426.01% reported on March 26. CareDx has consistently delivered positive results for the last three consecutive quarters, showcasing its operational strength. The operating cash flow reached a peak of USD 72.95 million, while pre-tax profit and net profit for the latest quarter grew by 204.24% and 203.07%, respectively. With a market capitalization of USD 859 million and a price-to-book ratio of 2.84, CareDx continues to solidify its position in the market. The company also boasts high institutional holdings at 100%, indicating strong confidence from institutional investors in its fundamentals.